PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer

Peroxisome proliferator-activated receptor-γ (PPAR-γ) has emerged as one of the most extensively studied transcription factors since its discovery in 1990, highlighting its importance in the etiology and treatment of numerous diseases involving various types of cancer, type 2 diabetes mellitus, auto...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballav, Sangeeta, Biswas, Bini, Sahu, Vishal Kumar, Ranjan, Amit, Basu, Soumya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601205/
https://www.ncbi.nlm.nih.gov/pubmed/36291082
http://dx.doi.org/10.3390/cells11203215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601205/
https://www.ncbi.nlm.nih.gov/pubmed/36291082
http://dx.doi.org/10.3390/cells11203215

Ejemplares similares